Vanguard Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$2.3B Buy
13,827,506
+84,365
+0.6% +$14.1M 0.03% 450
2025
Q3
$2.69B Buy
13,743,141
+1,693,918
+14% +$279M 0.04% 410
2025
Q2
$1.09B Buy
12,049,223
+2,751,747
+30% +$217M 0.02% 648
2025
Q1
$555M Buy
9,297,476
+85,846
+0.9% +$7.94M 0.01% 933
2024
Q4
$1.22B Buy
9,211,630
+7,186,582
+355% +$674M 0.02% 598
2024
Q3
$106M Buy
2,025,048
+21,253
+1% +$997K ﹤0.01% 1846
2024
Q2
$121M Buy
2,003,795
+288,357
+17% +$20M ﹤0.01% 1745
2024
Q1
$127M Buy
+1,715,438
New +$127M ﹤0.01% 1740

Other funds holding ALAB

Vanguard Group's ALAB Position: Q4 2025 in Review

Vanguard Group increased its Astera Labs (ALAB) stake by 0.61% in Q4 2025, buying an estimated $14.1M and bringing the position to 13,827,506 shares worth $2.3B. The position accounts for 0.03% of the portfolio, ranked #450.

Vanguard Group first reported a position in ALAB in Q1 2024 and has held it in 8 quarters since. The position peaked at $2.69B in Q3 2025. 701 funds tracked by Wall St. Rank hold ALAB as of Q4 2025.

  • Vanguard Group held 13,827,506 shares of Astera Labs worth $2.3B as of Q4 2025.
  • Vanguard Group bought 84,365 Astera Labs shares in Q4 2025, an estimated $14.1M.
  • Astera Labs made up 0.03% of Vanguard Group's portfolio in Q4 2025, its #450 holding.
  • Vanguard Group first reported a position in Astera Labs in Q1 2024 and has held it in 8 quarters since.
  • Vanguard Group's Astera Labs position peaked at $2.69B in Q3 2025.
  • 701 funds tracked by Wall St. Rank held Astera Labs as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.